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Abstract
Aims/hypothesis Our aim was to examine the association
between change in physical activity energy expenditure
(PAEE), total body movement (counts per day) and aerobic
fitness (maximum oxygen consumption [V
:
O2max]) over
1 year and metabolic risk among individuals with a family
history of diabetes.
Methods Three hundred and sixty-five offspring of people
with type 2 diabetes underwent measurement of energy
expenditure (PAEE measured using the flex heart rate method),
total body movement (daily activity counts from accelerometry
data), V
:
O2max predicted from a submaximal graded treadmill
exercise test and anthropometric and metabolic status at
baseline and 1 year (n=321) in the ProActive trial. Clustered
metabolic risk was calculated by summing standardised values
for waist circumference, fasting triacylglycerol, insulin and
glucose, blood pressure and the inverse of HDL-cholesterol.
Linear regression was used to quantify the association
between changes in PAEE, total body movement and fitness
and clustered metabolic risk at follow-up.
Results Participants increased their activity by 0.01 units
PAEE kJ kg−1 day−1 over 1 year. Total body movement
increased by an average of 9,848 counts per day. Change in
total body movement (β=−0.066, p=0.004) and fitness
(β=−0.056, p=0.003) was associated with clustered metabolic
risk at follow-up, independently of age, sex, smoking status,
socioeconomic status and baseline metabolic score.
Conclusions/interpretation Small increases in activity and
fitness were associated with a reduction in clustered meta-
bolic risk in this cohort of carefully characterised at-risk
individuals. Further research to quantify the reduction in risk
of type 2 diabetes associated with feasible changes in these
variables should inform preventive interventions.
Clinical trial registration number: ISRCTN61323766.
Keywords Cardio-respiratory fitness . Fitness .
Metabolic risk .Metabolic syndrome . Physical activity .
Syndrome X
Abbreviations
EE energy expenditure
FFM fat-free mass
HR heart rate
PAEE physical activity energy expenditure
REE resting energy expenditure
SES socioeconomic status
V
:
O2max maximum oxygen consumption
zMS continuously distributed metabolic
risk variable
zMS-ob continuously distributed metabolic
risk variable without the adiposity
component (waist circumference)
Introduction
The metabolic syndrome has been defined as a cluster of
closely related cardiovascular risk factors including visceral
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obesity, insulin resistance, hyperglycaemia, hypertension, hy-
pertriacylglycerolaemia and low HDL-cholesterol [1]. The
combination of these risk factors has been shown to predict
type 2 diabetes, cardiovascular disease and all-cause mortal-
ity [2], with physical inactivity identified as a major under-
lying risk factor. Given the rising prevalence of obesity and
type 2 diabetes, the metabolic syndrome represents a poten-
tially large public health burden [3, 4]. Previous research has
shown that low levels of physical activity are associated with
the metabolic syndrome [5, 6], and that objectively measured
physical activity energy expenditure (PAEE) predicts pro-
gression towards the metabolic syndrome independently of
obesity [7], with some evidence of interaction by cardiores-
piratory fitness [8, 9]. Additionally, lifestyle interventions
targeting physical activity as a modifiable risk factor have
shown positive effects upon various metabolic components
[10]. However, physical activity remains poorly measured in
most epidemiological studies, with many relying on self-
reporting [11]. Furthermore, it is unclear whether metabolic
risk is most effectively reduced by increases in overall
energy expenditure (EE), fitness or total body movement. A
better understanding of these relationships would inform the
development and targeting of individual and population-
based interventions to reduce risk of diabetes and related
metabolic disorders.
The ProActive (UK) trial is an explanatory trial of a
theory-based intervention to promote physical activity
among individuals reporting low levels of activity and who
are at increased risk of the consequences of a sedentary
lifestyle due to their family history of type 2 diabetes. The
main trial results are presented elsewhere [12]. We recently
observed a cross-sectional association between total body
movement and clustered metabolic risk in this cohort [13]
and are now extending these observations to examine the
association between change in objectively measured PAEE
(measured by individually calibrated heart rate [HR] moni-
toring), physical activity (total body movement measured by
accelerometry) and aerobic fitness and clustered metabolic
risk in the ProActive trial cohort over a period of 1 year.
Methods
The ProActive trial Full details of the study have been
reported elsewhere [14]. In brief, ProActive aimed to eval-
uate the efficacy of a theoretical, evidence- and family-based
intervention programme to increase physical activity among
individuals defined as high-risk through having a parental
history of type 2 diabetes. Potential participants were
identified via diabetes registers and medical records of
family history in 20 general practices in the East Anglia
region of the UK. Three hundred and sixty-five individuals
aged 30–50 years and reporting low levels of activity were
randomly assigned to one of three interventions: brief written
advice (control group), or a behavioural-change programme
at two levels of intensity delivered either by telephone
(distance) or face-to-face in the family home. The theory-
based intervention programme [15] was delivered by trained
facilitators and aimed to support increases in physical activity
through the introduction and facilitation of a range of self-
regulatory skills. Main trial results indicated no significant
difference in the 1 year change in objectively measured day-
time physical activity expressed as a ratio to resting EE
between the three trial arms [12]. Consequently, the three
trial arms were pooled and a cohort analysis conducted.
Complete data on PAEE, aerobic fitness, anthropometry and
biochemistry were available in 365 participants at baseline and
321 participants at follow-up, in addition to socio-demograph-
ic information. Total body movement measured by acceler-
ometry was also assessed in a subsample of participants (n=
192) at baseline and follow-up and the data were included in
these analyses. The measure of socioeconomic status (SES)
was based on age at finishing full-time education (above or
below 16 years). Ethics approval was obtained from the
Eastern England Multi-centre Research Committee (MREC)
and all participants gave written informed consent.
Anthropometric and metabolic tests Participants attended
the study centre after an overnight fast and a sample of
venous blood was taken. Fasting plasma glucose, serum
insulin levels and lipid profiles (cholesterol, triacylglycerol,
HDL- and LDL-cholesterol) were measured using the hexo-
kinase method and standard enzymatic methods, as described
previously [14]. Weight was measured on standard calibrat-
ed scales and height was measured using a rigid stadiometer.
BMI was calculated as weight (kg) divided by height (m)
squared. Waist circumference (cm) was measured over light
indoor clothing as the mid-point between the lower costal
margin and the level of the anterior superior iliac crests. Body
fat percentage was measured by bio-electrical impedance
(Bodystat, Isle of Man, UK), and systolic and diastolic blood
pressures were measured using an automated Accutorr
sphygmomanometer (Accutorr, Cambridge, UK).
Assessment of aerobic fitness, PAEE and total body
movement Aerobic fitness (maximum oxygen consumption
[V
:
O2max]) was predicted as oxygen uptake at maximal HR
(220 minus age [years]) by extrapolation of the regression
line established during the individual calibration for the
relationship between oxygen consumption and HR during a
submaximal graded treadmill exercise test. O2 uptake and
CO2 production was measured continuously by indirect
calorimetry throughout the test (Vista XT metabolic system;
Vacumed, Ventura, CA, USA).
Resting EE (REE) was calculated by the Weir formula
[16] using V
:
O2 and V
:
CO2 measurements obtained in the
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fasting state, after approximately 10 min of supine rest
using the same indirect calorimetry system as previously
described. PAEE was measured using the flex HR method
[8]. Flex HR was calculated as the mean of the highest
resting HR and the lowest HR while exercising. This point
was used in the analysis of free-living minute-by-minute
HR data to discriminate between rest and exercise. Below the
flex HR point, EE was assumed to be equivalent to REE. EE
above the flex point was predicted from the individual HR–
EE regression line. Participants wore HR monitors (Polar
Electro, Kemple, Finland) continuously during the waking
hours over the following 4 days. PAEE was calculated by
subtracting REE from the estimated average daily EE, and
thereafter averaged over the 4 day period. PAEE is body size
dependent, e.g. it requires more energy to move a heavier
body. Similarly, aerobic fitness is highly correlated with body
size or mass, e.g. larger individuals have a higher absolute
aerobic capacity. Therefore, body size is a confounding factor
that needs to be normalised for when analysing associations
between EE variables and metabolic outcomes [17]. As such,
both baseline and follow-up measures of aerobic fitness and
PAEE were expressed relative to fat-free mass (FFM; kJ kg−1
FFM min−1) to adjust for between-individual differences in
body size [17, 18].
Free-living total body movement was assessed with an
MTI Actigraph (formerly known as the CSA activity
monitor) model WAM7164 (Manufacturing Technology,
Fort Walton Beach, FL, USA). The accelerometer was worn
over the same 4 day period as the HR monitor. Participants
who did not manage to record at least 500 min/day of
activity for at least 3 days were excluded from analyses. A
customised program was used for data reduction and further
analyses (MAHUffe; http://www.mrc-epid.cam.ac.uk). The
outcome variable derived from accelerometry presented in
this study is total body movement (counts per day), adjusted
for monitored time, which is an indicator of the overall level
of physical activity.
Calculation of the metabolic syndrome z score A summary
score of clustered metabolic risk based on WHO criteria [1]
was calculated by summing standardised values for waist
circumference, triacylglycerol, fasting insulin and glucose,
systolic blood pressure and the inverse of HDL-cholesterol
[7–9]. Variables were standardised by subtracting the
sample mean from the individual mean and dividing by
the SD. Baseline and follow-up z scores were computed
with the same transformation, e.g. using the mean and SD of
baseline values. This continuously distributed metabolic risk
variable (zMS) was also calculated without the adiposity
component (i.e. waist circumference, zMS-ob). This clus-
tered metabolic risk score increases statistical power as
variables were not dichotomised, and includes a continuous
measure of glycaemia (unlike some other measures of
vascular risk [19]). Additionally, the International Diabetes
Federation criteria were used to define metabolic syndrome
as a dichotomous variable [1]. This score predicts hard
clinical endpoints [20].
Statistical analyses Descriptive summary statistics were
calculated separately for men and women using means and
SDs at baseline and follow-up. t tests were used to examine
whether there were any differences in baseline character-
istics between those with and without follow-up data, as
well as those with missing accelerometer data. Fasting
insulin and triacylglycerol values were log transformed (ln)
due to their non-normal distribution. In order to characterise
change in physical activity and fitness in the ProActive
cohort, we described the association between exposure
variables using correlation coefficients. We then examined
the proportion of metabolic syndrome and the mean clus-
tered metabolic risk score among participants who increased
and decreased their PAEE, fitness and total body movement
over 1 year. We used linear regression to model change in
PAEE and fitness (both per unit FFM), and total body move-
ment ([total counts per day]/1,000, adjusted for monitored
time), against individual subcomponents of the clustered
metabolic risk score at follow-up (waist circumference,
blood pressure, fasting triacylglycerol, insulin and glucose,
and the inverse of HDL-cholesterol). These models were
adjusted for age, sex, waist circumference (except when
waist circumference was modelled as the outcome), smoking
status, SES (assessed by self-reporting) and baseline pheno-
type, and were presented as standardised β-coefficients. We
then tested whether change in PAEE, fitness and total body
movement was associated with the clustered metabolic risk
score at follow-up. The first model (obesity dependent)
included all metabolic subcomponents (zMS) and was
adjusted for age, sex, smoking status, SES and baseline
zMS, while the second model excluded waist circumference
from the zMS (obesity independent zMS-ob) and was
adjusted for age, sex, smoking status, SES, baseline zMS-
ob and waist circumference. Finally, we examined whether
there was evidence of interaction between change in PAEE,
total body movement and aerobic fitness and clustered
metabolic risk, as well as interaction by age and sex. All
data were analysed in continuous form, although some data
were dichotomised for illustrative purposes. All analyses
were completed using Stata Version 8.0. (STATA, College
Station, TX, USA).
Results
Table 1 shows the anthropometric and metabolic character-
istics of participants with complete data for baseline and
follow-up (n=321) stratified by sex. More women met the
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inclusion criteria and agreed to take part in the study than
men. Participants with missing data at follow-up were slight-
ly shorter than those with complete data (difference=3.1 cm,
p<0.05) but not significantly different for all other baseline
variables. There were also no significant differences in
baseline characteristics between participants with and without
accelerometer data (data not shown). In general, men were
significantly taller and heavier than women but had a lower
percentage body fat at baseline. In terms of the six metabolic
syndrome subcomponents, waist circumference, systolic
blood pressure, triacylglycerol, fasting glucose and insulin
were all significantly higher in men, while HDL-cholesterol
was significantly higher in women. Statistically significant
differences were also observed for PAEE (kJ kg−1 FFM min−1)
and V
:
O2max (ml kg
−1 FFM min−1), with men achieving
higher levels of physical activity and fitness even after
adjustment for FFM. There were no significant differences in
total body movement between men and women at baseline.
For men, there were no significant differences in mean
height, weight, BMI, body fat, waist circumference, triacyl-
glycerol, HDL-cholesterol, fasting insulin and glucose from
baseline to follow-up. The only metabolic subcomponent
that changed significantly over time was systolic blood
pressure, which reduced from 127.1 to 124.5 mmHg. In
terms of the activity variables, men significantly increased
their physical activity (PAEE) from 0.125 to 0.139 kJ kg−1
FFM min−1, but increases in fitness and total body move-
ment did not achieve statistical significance. For women,
there were no significant differences in mean weight, body
fat, triacylglycerol, total cholesterol, HDL-cholesterol and
fasting insulin from baseline to follow-up. Mean height
decreased very slightly, while BMI increased from 27.6 to
27.8 kg/m2 and waist circumference increased from 87.9 to
89.2 cm. Values for both diastolic and systolic pressure
decreased significantly, while fasting plasma glucose in-
creased slightly from 4.7 to 4.8 mmol/l. Increases over the
year in PAEE, total body movement and fitness did not reach
statistical significance. There was no significant change in
the use of cardiovascular therapies during follow-up (data
not shown).
There was no evidence for a correlation between change in
fitness and change in PAEE (r=0.1) or total body movement
(r=0.0). There was limited evidence for a positive correlation
between change in PAEE and total body movement (r=0.3).
The overall prevalence of metabolic syndrome was 20% at
both baseline and follow-up, although there was some
movement between groups. The proportion of metabolic
syndrome at follow-up was higher among participants who
failed to increase their PAEE, fitness and total body move-
ment over 1 year (Fig. 1a). Similarly, clustered metabolic risk
scores were lower among individuals who managed to
increase their PAEE, fitness and total body movement during
follow-up (Fig. 1b). None of the differences between these
groups reached statistical significance but were in the
expected direction of effect.
Table 2 shows the crude and adjusted associations
between change in PAEE (kJ kg−1 FFM min−1), V
:
O2max
(ml kg−1 FFM min−1) and total body movement ([counts
Table 1 Anthropometric and metabolic characteristics of ProActive participants with complete baseline and follow-up data (n=321), stratified by
sex
Men Women
Baseline (n=129) Follow-up (n=129) Baseline (n=192) Follow-up (n=192)
Age (years) 40.2 (5.8) N/A 40.8 (6.1) N/A
Height (cm) 177.8 (6.8) 177.8 (7.0) 163.4 (6.1)a 163.2 (5.9)c
Weight (kg) 89.3 (15.5) 89.5 (15.6) 73.7 (14.6)a 74.0 (15.2)
BMI (kg/m2) 28.2 (4.3) 28.3 (4.4) 27.6 (5.2) 27.8 (5.4)d
Body fat (%) 25.6 (5.3) 25.8 (5.2) 34.6 (6.9)a 34.8 (7.1)
Waist circumference (cm) 100.3 (11.1) 100.9 (11.5) 87.9 (11.8)a 89.2 (12.5)c
Systolic blood pressure (mmHg) 127.1 (11.3) 124.5 (11.3)d 120.6 (13.8)a 116.8 (13.3)c
Diastolic blood pressure (mmHg) 81.4 (8.8) 79.6 (9.7)d 76.2 (9.3)a 73.9 (9.9)c
Triacylglycerol (mmol/l) 1.8 (1.6) 1.7 (1.3) 1.2 (0.6)a 1.1 (0.7)
Total cholesterol (mmol/l) 5.2 (1.0) 5.3 (1.0) 5.1 (0.9) 5.2 (1.0)
HDL-cholesterol (mmol/l) 1.2 (0.3) 1.2 (0.3) 1.6 (0.4)a 1.6 (0.4)
Fasting plasma insulin (mmol/l) 70.2 (71.6) 72.2 (52.3) 55.0 (35.6)b 56.3 (35.4)
Fasting plasma glucose (mmol/l) 5.1 (0.9) 5.2 (1.0) 4.7 (0.5)a 4.8 (0.5)d
PAEE (kJ kg−1 FFM min−1) 0.13 (0.07) 0.14 (0.08)d 0.10 (0.08)b 0.11 (0.07)
V
:
O2max (ml kg
−1 FFM min−1) 60.7 (10.54) 61.2 (11.42) 57.10 (10.72)b 58.06 (10.38)
Daily physical activity (total count)e 265,000 (79,000) 275,000 (106,000) 269,000 (109,00) 280,000 (110,000)
Data are means (SD)
a p<0.001, b p<0.05 for women vs men at baseline; c p<0.001, d p<0.05 for baseline vs follow-up (separately in men and women)
e These values are based on data from n=192 ProActive participants for whom accelerometer data were available at baseline and follow-up
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per day]/1,000) with standardised subcomponents of the
clustered metabolic risk score and the whole score (zMS) at
follow-up. As all outcomes are expressed in the same unit
(SD), it is possible to directly compare the magnitude of
associations between the different components of activity
with each of the outcomes, assuming they are measured
with the same degree of measurement error. In adjusted
analyses, fasting glucose, insulin and HDL-cholesterol at
follow-up were significantly associated with a change in
fitness over time; on average, individuals who increased
their fitness had reduced levels of glucose and insulin, and
increased levels of HDL-cholesterol at follow-up. Similarly,
fasting glucose and insulin were associated with change in
total body movement over time. All other subcomponents
of the clustered metabolic risk score failed to show an as-
sociation with change in either physical activity, fitness or
total body movement. In adjusted analyses, change in fitness,
but not change in PAEE, was associated with clustered
metabolic risk at follow-up with (zMS; p=0.034) and with-
out the obesity component (zMS-ob; p=0.04). In addition,
change in total body movement from baseline to follow-up
was associatedwith clustered metabolic risk in both the overall
(zMS; p=0.004) and obesity-independent score (zMS-ob;
p=0.01).
There was no evidence of interaction between change in EE
and aerobic fitness (p=0.28), EE and total body movement
(p=0.13) and aerobic fitness and total body movement (p=
0.13) with clustered metabolic risk at follow-up. While there
was no evidence of a significant interaction between age or
sex and change in the activity variables, the β-coefficients for
change in PAEE appeared stronger in men than in women,
and also in older rather than younger individuals.
Discussion
Our results suggest that small increases in physical activity,
measured using accelerometry and aerobic fitness, were
associated with improvement in clustered metabolic risk
over a 1 year period in middle-aged individuals at high risk
of developing type 2 diabetes. Our results were independent
of age, sex, smoking status, socioeconomic group and base-
line phenotype. This confirms our earlier cross-sectional re-
sult [13] in a prospective analysis, which provides stronger
inferential evidence for the association between total body
movement and metabolic risk. Further, this result is
supported by our finding that the proportion of metabolic
syndrome at follow-up was higher, albeit non-significantly,
among groups who failed to increase their PAEE, fitness and
total body movement over 1 year.
Although PAEE was not significantly associated with
clustered metabolic risk in our analyses, we were able to
demonstrate an association between overall body move-
ment (i.e. physical activity) assessed by accelerometry and
clustered metabolic risk. This is a novel finding given that
previous prospective associations between objectively mea-
sured physical activity and metabolic risk were observed in
a population of healthy middle-aged Europids [7], rather
than the overweight, sedentary younger adults with a high
risk of developing type 2 diabetes described in this cohort.
We also observed that the benefits of increased fitness and
total body movement acted primarily through changes in
serum glucose, insulin and HDL-cholesterol, which may
suggest that blood pressure is less sensitive to changes in
activity and fitness. In a comparable study, Ekelund et al.
[21] observed that an increase in activity was associated
with fasting insulin, triacylglycerol, 2 h glucose and clus-
tered metabolic risk but not with systolic or diastolic blood
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pressure. Contrary to our findings, previous literature has
shown an association between PAEE and clustered meta-
bolic risk, both cross-sectionally [8] and prospectively over
a period of 5.6 years, independently of fitness [7]. This
apparent discrepancy might be explained in a number of
ways. First, while the trial was powered to detect a difference
in physical activity-related EE between trial arms equivalent
to 2 metabolic energy equivalent (MET) h/day or approxi-
mately 30 min of brisk walking, the sample size was relatively
small for a cohort analysis and may not have been large
enough to detect smaller but still biologically important
differences. Nonetheless, all the PAEE β-coefficients were
in the same direction of effect as those for the accelerometry
data but they did not reach statistical significance.
Second, the precision in the methods we used to assess
PAEE and body movement may affect the observed associa-
tions. PAEE from individually calibrated HR monitoring is an
integrated measure of EE above rest calculated from free-
living HR data. In sedentary populations, much of the daytime
is spent in the region around the flex HR, which is used to
discriminate between rest and physical activity. The associa-
tion between HR and EE is less precise in this region, which
may influence the accuracy of predicted PAEE on an indi-
vidual level. Furthermore, the flex HR method may be
sensitive to the fitness level of the people under investigation
[22]. In contrast, accelerometry measures the vertical accel-
erations of the body, i.e. physical work, and is likely to be less
sensitive to the characteristics of the population in terms of a
sedentary lifestyle and fitness level. If most of the activities
performed are locomotor activities, such as walking, measure-
ment of body movement by accelerometry may be superior to
HR monitoring when examining associations with disease
risk. Ideally, the two different measurement techniques should
be combined into one single piece instrument [23].
Finally, by standardising the clustered metabolic risk score,
we assumed each component made an equal contribution
towards defining metabolic risk. It is unlikely that each com-
ponent is equally strongly associated with metabolic risk and
some variables will be more important that others in different
populations. It would therefore be ideal to weight each
component of the score, but data are currently unavailable.
Our results suggest that small, feasible changes in physical
activity (total body movement) and fitness in an at-risk
population may prevent progression towards the metabolic
syndrome. This supports previous literature, which has
demonstrated an inverse relationship between fitness, phys-
ical activity and risk of developing metabolic syndrome in a
number of settings [5, 24–26]. At a population level, our
findings have important implications. This group of middle-
aged, slightly overweight individuals, identified through
primary care registers via their first degree family history of
diabetes, represents an accessible population who might
benefit from increased physical activity and fitness levels.
Primary care or public health practitioners might target this
group for preventive action. Findings can also be extrapo-
lated to inform the characteristics of public health initiatives.
Increasing total body movement can be achieved through
small changes in lifestyle activity, such as taking the stairs
and parking the car further away from work, which may be
more palatable to sedentary and at-risk populations than
targeting changes in moderate to vigorous intensity activi-
ties. Regular physical activity participation also has multiple
positive effects upon other diseases in addition to metabolic
syndrome, such as stroke, coronary heart disease and cancer
[27, 28]. However, currently there is limited evidence regard-
ing the effectiveness of lifestyle interventions for individuals,
at-risk groups or populations in the treatment and prevention
of metabolic syndrome and this is an area of research that
warrants further investigation. It is important to clarify whether
metabolic risk is most effectively reduced by increases in
overall EE, fitness or total body movement to inform the
development and nature of preventive interventions.
This study had several methodological strengths. The
ProActive trial allowed objective measurement of several
components of physical activity and fitness over a period of
12 months in a well-defined group of individuals accessed
through primary care who were at risk of diabetes. There
was a high follow-up rate (88%) and standardised measures
were used throughout. We used objective measures of
physical activity, which reduces the error and bias com-
monly associated with self-report measures and our objec-
tive measures of EE, physical activity (PAEE, total body
movement) and fitness have been extensively validated in
the laboratory and during free-living conditions [18].
In conclusion, small increases in physical activity assessed
by accelerometry and in aerobic fitness were associated with
improvedmetabolic risk over 1 year. Further research is needed
to clarify the relationship between physical activity, EE, fitness
and metabolic risk to inform advice and intervention develop-
ment. We may need even more precise methods of measure-
ment to capture the true dose effect of such relationships.
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